Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Nadali

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Hematotherapy & Stem Cell Research|November 25, 2000
Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lumphomaA Corato, A Ambrosetti, B Rossi, et al.
Leukemia|April 1, 1994
Detection of membrane and intracellular antigens by flow cytometry following ORTHO PermeaFix fixationG Pizzolo, C Vincenzi, G Nadali, et al.
British Journal of Haematology|May 1, 1993
ICAM-1 tissue overexpression associated with increased serum levels of its soluble form in Hodgkin's diseaseG Pizzolo, F Vinante, G Nadali, et al.
AIDS (London, England)|June 1, 1994
High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDSG Pizzolo, F Vinante, L Morosato, et al.
Leukemia|March 1, 1994
Relationship between Daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemiaG Todeschini, V Meneghini, G Pizzolo, et al.
Cancer|July 1, 1993
Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcomeA Ambrosetti, G Nadali, F Vinante, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosisG Nadali, F Vinante, A Ambrosetti, et al.
Haematologica|September 1, 1994
Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosisF Vinante, L Morosato, F Siviero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large-cell lymphomaG Nadali, F Vinante, H Stein, et al.
Haematologica|February 9, 1999
Regulation of the proliferative potential of cord blood long-term culture-initiating cells (LTC-IC) by different stromal cell lines: implications for LTC-IC measurementG Nadali, E A de Wynter, F Perandin, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Hematotherapy & Stem Cell Research|November 25, 2000
Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lumphomaA Corato, A Ambrosetti, B Rossi, et al.
Leukemia|April 1, 1994
Detection of membrane and intracellular antigens by flow cytometry following ORTHO PermeaFix fixationG Pizzolo, C Vincenzi, G Nadali, et al.
British Journal of Haematology|May 1, 1993
ICAM-1 tissue overexpression associated with increased serum levels of its soluble form in Hodgkin's diseaseG Pizzolo, F Vinante, G Nadali, et al.
AIDS (London, England)|June 1, 1994
High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDSG Pizzolo, F Vinante, L Morosato, et al.
Leukemia|March 1, 1994
Relationship between Daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemiaG Todeschini, V Meneghini, G Pizzolo, et al.
Cancer|July 1, 1993
Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcomeA Ambrosetti, G Nadali, F Vinante, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosisG Nadali, F Vinante, A Ambrosetti, et al.
Haematologica|September 1, 1994
Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosisF Vinante, L Morosato, F Siviero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Serum levels of the soluble form of CD30 molecule as a tumor marker in CD30+ anaplastic large-cell lymphomaG Nadali, F Vinante, H Stein, et al.
Haematologica|February 9, 1999
Regulation of the proliferative potential of cord blood long-term culture-initiating cells (LTC-IC) by different stromal cell lines: implications for LTC-IC measurementG Nadali, E A de Wynter, F Perandin, et al.
Pageof 4